ForSight Robotics Secures $125M to Revolutionize Ophthalmic Surgery
Table of Contents
- ForSight Robotics Secures $125M to Revolutionize Ophthalmic Surgery
- ORYOM™ Platform: Aims to Transform Eye Surgery
- Addressing the Global shortage of Ophthalmologists
- The Growing Need for Advanced Ophthalmic Solutions
- Frequently Asked questions About Robotic Ophthalmic Surgery
- What is the ORYOM™ platform, and how does it work?
- What are the potential benefits of robotic surgery for cataract patients?
- How does ForSight Robotics plan to address the global shortage of ophthalmologists?
- What is the current status of clinical trials for the ORYOM™ platform?
- How much funding has ForSight Robotics raised to date?
- What other eye conditions could be treated using the ORYOM™ platform in the future?
Israeli medtech innovator ForSight Robotics has successfully closed a $125 million Series B funding round, spearheaded by Eclipse, to propel its ORYOM™ platform, the world’s first robotic surgery system designed for cataract adn other eye-related ailments, into its next phase of growth. This funding will support upcoming first-in-human clinical trials [1].
ORYOM™ Platform: Aims to Transform Eye Surgery
The ORYOM™ platform is engineered to enhance surgical precision, broaden patient access to top-tier treatment, and alleviate the physical demands on surgeons. The funding round saw meaningful investment from an undisclosed strategic investor, Dr. Fred Moll, the Adani Group, Reiya Ventures, and existing investors, bringing ForSight Robotics’ total funding to $195 million.
Did You Know? The global ophthalmic market is projected to reach $68.7 billion by 2029, growing at a CAGR of 5.8% from 2022 [2].
AI-Powered Precision for Cataract and Beyond
specifically designed for consistent and highly precise ophthalmic procedures, starting with cataract surgery, the ORYOM™ platform leverages artificial intelligence (AI)-based algorithms, advanced computer vision, and micromechanics. This robotic surgery platform offers unprecedented dexterity and maneuverability, while also improving the ergonomic experience for surgeons. The platform can access any point within the human eye, enabling surgeons to navigate complex angles and access both anterior and posterior segments, paving the way for glaucoma and retinal surgical treatments.
Addressing the Global shortage of Ophthalmologists
The rise of ForSight Robotics comes at a crucial time. Globally, there are only 31.7 ophthalmologists per million population and just 14.1 cataract surgeons per million population. By 2035, a 12% decline in ophthalmologists is expected, while demand is projected to increase by 24%. Currently, over 600 million people worldwide suffer from cataracts, but only 30 million receive surgical treatment.
Pro Tip: Early detection and treatment of eye conditions can significantly improve patient outcomes and reduce the burden on healthcare systems.
Key Metrics: Ophthalmologists and Cataract Patients
| Metric | Current Status | Projection (2035) |
|---|---|---|
| Ophthalmologists per million population | 31.7 | Decline of 12% |
| Cataract Surgeons per million population | 14.1 | Data Not Available |
| Cataract Patients | 600 Million | Demand Increase of 24% |
| Cataract surgeries Performed | 30 Million | Data Not Available |
How will robotic surgery impact the accessibility of eye care in underserved communities? What are the potential long-term benefits of AI-powered surgical precision for patients?
The Growing Need for Advanced Ophthalmic Solutions
The increasing global population, coupled with longer life expectancies, is driving a surge in age-related eye conditions such as cataracts, glaucoma, and macular degeneration. Conventional surgical methods, while effective, can be physically demanding on surgeons and may not always be accessible to patients in remote or underserved areas. This has created a pressing need for innovative solutions that can enhance surgical precision, improve patient outcomes, and expand access to quality eye care.
Robotic surgery platforms like ORYOM™ represent a significant step forward in addressing these challenges. By leveraging AI, advanced imaging, and microrobotics, these systems can provide surgeons with enhanced control and precision, enabling them to perform complex procedures with greater accuracy and efficiency. furthermore, the potential for remote surgery and telemedicine applications could extend the reach of specialized ophthalmic care to patients in even the most remote locations.
Frequently Asked questions About Robotic Ophthalmic Surgery
What is the ORYOM™ platform, and how does it work?
The ORYOM™ platform is a robotic surgery system developed by ForSight Robotics for performing cataract and other eye surgeries. It uses AI-based algorithms,advanced computer vision,and micromechanics to enhance surgical precision and improve the ergonomic experience for surgeons.
What are the potential benefits of robotic surgery for cataract patients?
Robotic surgery offers several potential benefits for cataract patients, including increased surgical precision, reduced risk of complications, faster recovery times, and improved visual outcomes.
How does ForSight Robotics plan to address the global shortage of ophthalmologists?
By enhancing surgical efficiency and expanding access to quality eye care, the ORYOM™ platform can help address the global shortage of ophthalmologists. The platform’s ability to improve surgical precision and reduce physical strain on surgeons may also attract more individuals to the field of ophthalmology.
What is the current status of clinical trials for the ORYOM™ platform?
ForSight Robotics is preparing to launch first-in-human clinical trials for the ORYOM™ platform this year.These trials will evaluate the safety and efficacy of the platform in performing cataract and other eye surgeries.
How much funding has ForSight Robotics raised to date?
with the completion of the $125 million Series B funding round, ForSight Robotics has raised a total of $195 million to date. This funding will support the continued advancement and commercialization of the ORYOM™ platform.
What other eye conditions could be treated using the ORYOM™ platform in the future?
While the ORYOM™ platform is initially designed for cataract surgery,it has the potential to be used for treating other eye conditions,such as glaucoma and retinal diseases. The platform’s ability to access any point within the human eye makes it a versatile tool for a wide range of ophthalmic procedures.
Disclaimer: This article provides general details about ForSight Robotics and its ORYOM™ platform and should not be considered medical advice. Consult with a qualified healthcare professional for any health concerns or before making any decisions related to your medical treatment.
Share this article and join the discussion! What advancements in medical technology are you most excited about?